Anhui Huaren Health Pharmaceutical Past Earnings Performance
Past criteria checks 2/6
Anhui Huaren Health Pharmaceutical has been growing earnings at an average annual rate of 15.3%, while the Consumer Retailing industry saw earnings growing at 3.5% annually. Revenues have been growing at an average rate of 19.1% per year. Anhui Huaren Health Pharmaceutical's return on equity is 7.2%, and it has net margins of 3.1%.
Key information
15.3%
Earnings growth rate
11.7%
EPS growth rate
| Consumer Retailing Industry Growth | 12.8% |
| Revenue growth rate | 19.1% |
| Return on equity | 7.2% |
| Net Margin | 3.1% |
| Last Earnings Update | 30 Sep 2024 |
Recent past performance updates
Recent updates
Revenue & Expenses Breakdown
How Anhui Huaren Health Pharmaceutical makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 30 Sep 24 | 4,388 | 135 | 1,128 | 36 |
| 30 Jun 24 | 4,234 | 129 | 1,066 | 35 |
| 31 Mar 24 | 4,056 | 133 | 1,016 | 28 |
| 31 Dec 23 | 3,797 | 115 | 964 | 24 |
| 30 Sep 23 | 3,703 | 180 | 930 | 11 |
| 30 Jun 23 | 3,584 | 177 | 885 | 8 |
| 31 Mar 23 | 3,431 | 175 | 851 | 6 |
| 01 Jan 23 | 3,262 | 161 | 808 | 4 |
| 01 Jan 22 | 2,339 | 70 | 692 | 0 |
| 31 Dec 20 | 1,931 | 89 | 564 | 0 |
| 31 Dec 19 | 1,522 | 52 | 483 | 0 |
| 31 Dec 18 | 1,105 | 20 | 377 | 0 |
Quality Earnings: 301408 has high quality earnings.
Growing Profit Margin: 301408's current net profit margins (3.1%) are lower than last year (4.9%).
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: 301408's earnings have grown by 15.3% per year over the past 5 years.
Accelerating Growth: 301408's has had negative earnings growth over the past year, so it can't be compared to its 5-year average.
Earnings vs Industry: 301408 had negative earnings growth (-25.4%) over the past year, making it difficult to compare to the Consumer Retailing industry average (6%).
Return on Equity
High ROE: 301408's Return on Equity (7.2%) is considered low.